Highlights
1 patentProfile claimed by owner
About
Novel Antibiotics for Targeting Resistant Bacteria
SuperTrans Medical is a biopharmaceutical company developing novel antibiotics that target difficult-to-treat, multidrug-resistant bacteria often known as superbugs. The companys guanidinium-rich molecular transporter (GR-MoTr) technology used in conjunction with existing FDA-approved antibiotics results in superior antimicrobial properties. SuperTrans Medical is committed to an expedited development program and a shorter path to the clinic.
Identity
| Name | SuperTrans Medical |
|---|---|
| Slug | supertrans-medical |
| Type / kind | startup |
| Crunchbase ID | supertrans-medical |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4O6JuaoLDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Ness Ziona |
| HQ address | Pinhas Sapir Street 3, Ness Ziona, Israel |
Web & social
| Website | https://www.supertrans-medical.com/site/content/ |
|---|---|
| https://www.linkedin.com/company/65341530 | |
| Twitter / X | https://twitter.com/SuperTransMedi1 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
biotechnologybiopharmaceuticaloncologypharmaceuticalsdrug-discoverytherapeuticsdrug-deliveryantibiotics
Funding
| Total raised | $2.0M |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}